Luly Jay R.
President and CEO
Luly Jay R. has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Feb 13, 2026.
On the most recent filing, Luly Jay R. is listed as President and CEO at ENANTA PHARMACEUTICALS INC. Inside the rolling window, Luly Jay R. reported no open-market purchases and 1 open-market sale totaling $67K in ENTA.
Companies traded
Other insiders at ENTA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$67K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Luly Jay R. made?
Luly Jay R. has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does Luly Jay R. trade?
Luly Jay R. has filed SEC Form 4 disclosures for 1 company, including ENTA.
When was Luly Jay R.'s most recent SEC Form 4 filing?
Luly Jay R.'s most recent SEC Form 4 filing on Tracefour is dated Feb 13, 2026.
What is Luly Jay R.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Luly Jay R. is listed as President and CEO.
What is Luly Jay R.'s total buy and sell value in the current window?
Inside the rolling retention window, Luly Jay R. bought $0 and sold $67K based on SEC Form 4 filings.
What was Luly Jay R.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 4,743 ENTA shares on 2025-12-05, worth $67K, per SEC Form 4 filings.